Chelsea Counsel Company’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$68.7K Sell
891
-250
-22% -$18.2K 0.03% 130
2026
Q1
$74.5K Sell
1,141
-882
-44% -$65.5K 0.03% 124
2025
Q4
$160K Sell
2,023
-6,887
-77% -$527K 0.07% 103
2025
Q3
$650K Sell
8,910
-1,685
-16% -$124K 0.29% 59
2025
Q2
$804K Buy
10,595
+9,304
+721% +$659K 0.4% 49
2025
Q1
$98.2K Sell
1,291
-25
-2% -$1.86K 0.05% 116
2024
Q4
$86.9K Hold
1,316
0.04% 113
2024
Q3
$91.8K Sell
1,316
-2
-0.2% -$120 0.05% 114
2024
Q2
$69.7K Buy
+1,318
New +$80K 0.03% 120

Other funds holding SOLV

Chelsea Counsel Company's SOLV Position: Q2 2026 in Review

Chelsea Counsel Company reduced its Solventum (SOLV) stake by 22% in Q2 2026, selling an estimated $18.2K and leaving 891 shares worth $68.7K. The position accounts for 0.03% of the portfolio, ranked #130.

Chelsea Counsel Company first reported a position in SOLV in Q2 2024 and has held it in 9 quarters since. The position peaked at $804K in Q2 2025. 883 funds tracked by Wall St. Rank hold SOLV as of Q2 2026.

  • Chelsea Counsel Company held 891 shares of Solventum worth $68.7K as of Q2 2026.
  • Chelsea Counsel Company sold 250 Solventum shares in Q2 2026, an estimated $18.2K.
  • Solventum made up 0.03% of Chelsea Counsel Company's portfolio in Q2 2026, its #130 holding.
  • Chelsea Counsel Company first reported a position in Solventum in Q2 2024 and has held it in 9 quarters since.
  • Chelsea Counsel Company's Solventum position peaked at $804K in Q2 2025.
  • 883 funds tracked by Wall St. Rank held Solventum as of Q2 2026.

Based on Chelsea Counsel Company's 13F filing for Q2 2026, filed 12 Aug 2026.